Page 3 - பீட்சன் மேற்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பீட்சன் மேற்கு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பீட்சன் மேற்கு Today - Breaking & Trending Today

First new treatment in decades for patients with rare form of bowel cancer


Patients diagnosed with a BRAF-mutated bowel cancer in Scotland will have a new treatment available to them if the disease is found to have spread
PATIENTS in Scotland with a rare but particularly deadly form of colorectal cancer will have access to a new life-extending therapy on the NHS for the first time.
The Scottish Medicines Consortium has given the go ahead for Braftovi to be used in combination with cetuximab in patients whose cancer has the BRAF V600 genetic mutation.
This is present in around 15 per cent of patients with early-stage colorectal cancer and 6% of those whose disease has spread, with patients in this latter category typically surviving just four to six months from diagnosis. ....

Glasgow City , United Kingdom , Janet Graham , Emily Meunier , Genevieve Edwards , Scotland Cancer Centre , Beatson West , Bowel Cancer United Kingdom , கிளாஸ்கோ நகரம் , ஒன்றுபட்டது கிஂக்டம் , ஜேனட் கிரஹாம் , ஜெநிவீவ் எட்வர்ட்ஸ் , ஸ்காட்லாந்து புற்றுநோய் மையம் , பீட்சன் மேற்கு , குடல் புற்றுநோய் ஒன்றுபட்டது கிஂக்டம் ,

Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use


Medicines for colorectal, skin and ovarian cancers are among four newly approved treatements for use in NHS Scotland.
The Scottish Medicines Consortium (SMC) announced it has accepted four new medicines for routine use from Monday including Encorafenib (Braftovi), hydrochloride (Ledaga), niraparib (Zejula) and Ravulizumab (Ultomiris).
Encorafenib (Braftovi) was accepted for use along with the medicine cetuximab for the treatment of colorectal cancer in patients with a gene mutation called “BRAF V600”.
It can be used when the cancer has spread elsewhere in the body after previously being treated with other medicines.
Great news for advanced #bowelcancer patients with a BRAF mutation living in Scotland. The Scottish Medicines Consortium has today approved BRAFTOVI® (encorafenib). This new drug offers hope to patients with very limited treatment options: https://t.co/LcCiOc6IQApic.twitter.com/BkSzRHAvaF ....

United Kingdom , Janet Graham , Encorafenib Braftovi , Mark Macgregor , Ravulizumab Ultomiris , Scotland Cancer Centre , Beatson West , Clinician Engagement , ஒன்றுபட்டது கிஂக்டம் , ஜேனட் கிரஹாம் , குறி மேக்ரிகோர் , ஸ்காட்லாந்து புற்றுநோய் மையம் , பீட்சன் மேற்கு , மருத்துவர் நிச்சயதார்த்தம் ,

Nico Simeone to open charitable restaurant Beat 6 in Glasgow


Nico Simeone to open charitable restaurant Beat 6 in Glasgow
The team behind the Six by Nico group of restaurants is opening a new venue that will donate its profits to charity.
Called Beat 6, the restaurant, to be located on Whitehill Street in the Dennistoun are of Glasgow, will donate its profits towards the Beatson Cancer Charity, which supports the Beatson West of Scotland Cancer Centre
Restaurateur Nico Simeone and his wife Valentina have created the project to help the Beatson Cancer Charity help others in the same way it helped them. Valentina has benefitted from the treatment the Beatson provides having been diagnosed with Non-Hodgkin’s Lymphoma in May of 2015, at the age of 25.  ....

Glasgow City , United Kingdom , Nico Simeone , Scotland Cancer Centre , Beatson Cancer Charity , Called Beat , Whitehill Street , Beatson West , Scotland Cancer , கிளாஸ்கோ நகரம் , ஒன்றுபட்டது கிஂக்டம் , நிகோ சிமேோனே , ஸ்காட்லாந்து புற்றுநோய் மையம் , பீட்சன் புற்றுநோய் தொண்டு , வைட்ஹில் தெரு , பீட்சன் மேற்கு , ஸ்காட்லாந்து புற்றுநோய் ,